vedolizumab
takeda
[' vedo', 'ibd', 'vedo', 'crohn', 'vedolizumab']
geert d haens presents the first results of the reprevio trial, examining the use of vedolizumab to prevent postoperative recurrence of crohn s disease #ibd #gitwitter #eccc2023 #ecco23 
The Lancet Gastroenterology & Hepatology is the world-leading #gastroenterology and #hepatology research journal. IF=45.042. #Lancet200